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Abstract 
Heart disease, including coronary artery disease, affects approximately 42 million women 
in the United States.  Many of those affected are not aware they have the condition. 
Contributing to the problem is the fact that women are more likely than men to be 
misdiagnosed and undertreated for heart disease.  Morbidity and mortality are high in 
women affected by heart disease, making the problem important to address.  The purpose 
of this project was to understand the coronary artery or heart disease risk and the 
treatment for the condition provided for 31 participants at a cardiology service in the 
Northeast U.S.  The project question focused on understanding how coronary artery 
disease manifest in women and the gender differences in treatment for men and women.  
A descriptive case design was used by gathering data from patient risk profiles and 
treatments.  Participants were males and females aged between 30 and 80.   Qualitative 
data were obtained through cardiology staff interviews and existing literature.  The data 
were subjected to a content analysis to identify emergent themes.  Findings indicated that 
the women experienced different cardiac symptoms to men, and these differences 
translated to misdiagnosis and resulting treatment ineffectiveness.  This project 
contributes to social change through raising awareness of the gender differences in heart 
disease presentation so that providers can recognize and treat the condition effectively.    
 
  
Women and Coronary Artery Disease 
by 
Gwendolyn Y. Stancell-Smith 
 
MSN, Walden University, 2013 
BSN, Point Loma Nazarene University, 1994 
 
Project Submitted in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Nursing Practice 
 
 
Walden University 
 February 2017 
Dedication 
My mother, Thora Y. Stancell, and my late father, Woodrow W. Stancell, are the 
inspiration for completing the doctoral program.  They worked effortlessly and endured 
many trials in order for me to have an education.   . 
Acknowledgements 
I want to thank God the father up above for showing me mercy and grace.  I thank 
all of my instructors who have guided my path.  Thank you to all of my classmates for 
this journey.  I thank my love and boyfriend, Eric D. Carter, for proof reading my work 
and helping to solve IT problems. 
 i 
Table of Contents 
List of Tables ..................................................................................................................... iii 
List of Figures .................................................................................................................... iv 
Section 1: Introduction of the Problem ................................................................................1 
Background ....................................................................................................................1 
Statement of the Problem ...............................................................................................5 
Purpose of the Study ......................................................................................................6 
Project Questions ...........................................................................................................8 
Definition of Terms....................................................................................................... 8 
Theoretical Framework ................................................................................................. 9 
Evidence-Based Significance of the Problem ............................................................. 11 
Social Determinants .................................................................................................... 11 
Economic Factors........................................................................................................ 12 
Implications for Social Change in Nursing Practice ................................................... 12 
Summary of the Practice Problem and the Project ......................................................13 
Section 2: Review of Literature .........................................................................................14 
Introduction ..................................................................................................................14 
Coronary Artery Disease and Gender Differences ..................................................... 15 
Section 3: Methodology .....................................................................................................17 
Project Design ..............................................................................................................17 
Participants ............................................................................................................ 17 
Materials ............................................................................................................... 18 
Sampling ............................................................................................................... 18 
 ii 
Instrumentation ............................................................................................................18 
Data Collection and Analysis Procedures ....................................................................22 
Protection of Human Rights.........................................................................................22 
Descriptive Studies ......................................................................................................23 
Case Series .................................................................................................................. 23 
Significance of the Study .............................................................................................23 
Section 4: Findings, Discussion, and Implications ............................................................25 
Case Scenarios .............................................................................................................25 
Discussion of Findings .................................................................................................39 
Implications..................................................................................................................44 
Project Strengths and Limitations ................................................................................45 
Analysis of Self ............................................................................................................46 
Section 5: Scholarly Product for Dissemination ................................................................47 
Summary ............................................................................................................................48 
References ......................................................................................................................... 66 
 
  
 iii 
List of Tables 
Cardiovascular Disease in Women Chart ..........................................................................54 
Table 1: Classification of CAD in women  ........................................................................... 64 
 
  
 iv 
List of Figures 
Figure A: How does Heart Disease affect women? .......................................................... 65 
1 
 
Section 1: Introduction of the Problem 
Background 
Heart disease is a condition in which the major blood vessels to the heart are blocked or 
narrowed.  It is also referred to as cardiovascular disease. Heart disease can eventually 
lead to an individual experiencing a heart attack, stroke, or angina pain.  There are several 
other heart disorders that can have adverse reactions on the heart muscle, heart rate, and 
heart valves leading to coronary heart disease.  Lifestyles void of cigarette smoking and 
alcohol usage that includes a balanced diet and exercise on a regular basis may help to 
prevent heart disease.   
 In the United States, over 40 million women are living with cardiovascular 
disease; most are not aware of having the disease.  Health practitioners are beginning to 
acknowledge the widespread of cardiovascular disease in women, though heart disease 
over the decades has only been linked to men.  Over 400 million women die from heart 
disease in the United Stated yearly.  The impact of heart disease is affecting women 
globally, and is being recognized as the focal cause of death.  There have been a few 
studies to examine cardiovascular disease in women; the clinical trials that have been 
performed only represent 30% of women in the population, (Jouria, 2015).  Diagnosing 
of heart disease and treatment modalities use in women are sublime, compared to men.  
Medications used to treat heart disease in women, may cause a different chemical 
reaction that is less desirable, (Jouria, 2015).  Furthermore, Jouria (2015, p.13), states, 
About one in three women (34.9%) in the United States have some kind of 
cardiovascular problem.  Approximately, one in seven women dies of a cardiovascular 
disease, whereas one in four women dies of cancer.  Though age-based mortality rates of 
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cardiovascular disease is higher in men, the total number of cardiovascular-related deaths 
has been higher in women over the past 20 years, mainly because of a longer life 
expectancy and a larger population of older women. 
Evidence-based guidelines to prevent heart disease specifically in women were 
established by the American Heart Association in 2011 and updated in 2012.  According 
to Jouria (2015), evidence based practice has been the key to providing optimum care, but 
now it has advanced to how preventative measures effect overall quality of care and cost. 
There are certain risk factors and comorbidities relating to developing heart 
disease.  The risk factors are obesity, lack of exercise, diabetes, and hypertension.  
However, aspects of population diversity beyond the known classifications of race, 
ethnicity, and demographic location can affect the development of heart disease, how it is 
treated and the quality of care provided.  Other such important factors are literacy skills, 
age, culture, socioeconomic status, religion, disability status, and occupation (Jouria, 
2015). 
In order for the heart to properly function, oxygen rich blood must supply the 
heart muscle.  Coronary artery disease is a disease that prevents this from occurring, as 
plaque builds up inside of the coronary arteries.  According to Jouria (2015), 
atherosclerosis is the condition that occurs, when plaque lines the walls of arteries, 
causing them to harden.  This process can occur over several years.  Due to sclerosis of 
the arteries from plaque buildup, there is less oxygen rich blood to perfuse the heart.   
Heart attacks can occur when the plaque within the coronary vessels dislodge, 
leading to the formation of a blood clot.  When the flow of blood is blocked to any area 
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of the heart, the muscle can die.  Heart attacks are considered a medical emergency.  
Swift intervention is needed to prevent death.  
 High blood pressure can cause hypertensive heart disease.  When the walls of the 
heart are thickened, it causes the load of the heart to work less efficiently and harder.  
This leads to developing coronary artery disease and heart failure.  High blood pressure 
increases morbidity and mortality.   
A heart that does not beat properly or is weak can lead to the development of a 
cardiomyopathy.  Many types of cardiomyopathies exist.  Depending on what type of 
cardiomyopathy a person may exhibit, it will affect the heart’s functioning capacity.  
Cardiomyopathy affects the way blood is pump from the heart to the rest of the body.  
The heart muscle is diseased.  The most common type of cardiomyopathy is dilated 
cardiomyopathy.  This type of cardiomyopathy weakens the walls of the heart, and 
affects the heart chambers.  It is also considered idiopathic cardiomyopathy, because it 
remains unknown why it occurs.  When there are blocked arteries, and narrowing of the 
heart vessels, oxygen cannot reach the heart muscle adequately; this is referred to as 
ischemic cardiomyopathy.  When the chambers of the heart cannot properly fill with 
blood, and the heart is unable to stretch appropriately, this is called restrictive 
cardiomyopathy.  Thickening of the heart walls is referred to as hypertrophic 
cardiomyopathy.  This type of cardiomyopathy can affect people of any age group. 
Problems can occur with the valves of the heart.  There are four valves to the 
heart: the aortic, pulmonic, mitral, and tricuspid valves.  Every time the heart beats there 
is a small piece of tissue, similar to a flap that opens and closes.  The flap serves the 
purpose of closing off blood flow or allowing blood flow to enter through the valves and 
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into the chambers of the heart as well as the rest of the body.  A person can experience 
shortness of breath, chest pain, swollen lower extremities, and tiredness.  The cause can 
be the insufficiency of the heart valves operating.  Heart valves make sure that blood flow 
is unidirectional, and blood does not flow backwards.  A heart valve may not close 
tightly, where there is blood leaking backwards through the valve; this is called 
regurgitation.  Stenosis of a valve can occur when the valve does not open up enough, 
and the flow of blood is blocked.  
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Statement of the Problem 
The disease burden of coronary artery disease for women has been overlooked.  
The affects of coronary artery disease is distinct in men and women.  Cardiovascular 
disease (CVD) in women manifests on a level completely opposite to disease processes, 
and clinical appearances routinely observed in men.  This makes the diagnosing of CVD 
in women much harder to distinguish, and leaves women susceptible to not receiving the 
correct desirable intervention.  Women are more likely to experience disability, or worse 
death from CVD.  Research specific to differences of coronary artery disease, based off 
of gender, is bringing to light, that CVD in women needs more investigating, (Aziz, 
2014). 
Women, who have the condition known as atherosclerosis, are more prone to 
developing blood clots.  Women can present with no evidence of the coronary arteries 
being blocked, but can still have ischemia.  The inner lining of the blood vessels can be 
affected, where there is dysfunctioning of the endothelial cells that can cause either 
vasodilation, or vasoconstriction responses.  Women can experience small vessel disease, 
where the small vessels of the heart are damaged, causing angina pain to be experienced, 
(Aziz, 2014).  
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Purpose of the Study 
The purpose of this study is to determine why heart disease differs in men and 
women.  It is an important factor to note that women have smaller hearts than men; 
specifically the right ventricle.  The pumping mechanism of the right side of the heart is 
crucial for optimal functioning.  According to the American Heart Association’s 
movement titled, Go Red for Women (2016), they identified that there are several 
conditions linked to the functioning of the right side of the heart in women; specific lung 
diseases such as sleep apnea, pulmonary hypertension, and chronic obstructive 
pulmonary disease.  The right ventricle of a woman’s heart is smaller than a man’s right 
ventricle.  The inability of the right ventricle to sufficiently pump blood to the lungs, in 
order to pick up oxygen, causes the right ventricle to enlarge.  According to Mercuro et al 
(2010),  
Gender differences in the cardiovascular system and sex diversity in genetic 
susceptibility to CVD were recognized and appreciated only recently. Men are born with 
XY chromosomes, and women are born with XX chromosomes.  Men and women differ 
from every cell and molecule from each other.  Every cell is sexually differentiated and 
there exist postpuberal differences between male and female cardiovascular systems 
(p.207).  
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The strength of the study is its aim to raise awareness of how coronary artery 
disease affects women and treatment modalities specific for women in combating the 
disease.  The study will not be able to stop women from being misdiagnosed, 
undertreated, and misrepresented concerning coronary artery disease.  Women tend to 
wait too long in seeking any care professionally, and their condition can already be in an 
advanced phase, (Mercuro et al, 2010).   
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Project Questions 
For the purpose of this study the following questions are addressed: 
1:  How does coronary artery disease present in women compared to men? 
2:  What are the differences between coronary artery disease treatments for 
women compared to men?  
Definition of Terms 
Coronary artery disease (CAD), according to the Mayo Clinic (2015), “develops 
when the major blood vessels that supply your heart with blood, oxygen, and nutrients 
(coronary arteries) become damaged or diseased.  Cholesterol containing deposits 
(plaque) in your arteries and inflammation are usually, to blame for coronary artery 
disease” (p.1).  A heart attack can occur if the coronary arteries are completely blocked.  
An individual can experience chest pain and shortness of breath if there is a decrease in 
blood flow to the heart muscle, caused by narrowed coronary arteries (Mayo Clinic, 
2015). 
Low density lipoproteins (LDL), according to the Centers for Disease Control and 
Prevention (2015b), “make up the majority of the body’s cholesterol.  LDL is known 
as‘bad’ cholesterol because having high levels can lead to plaque buildup in the arteries 
and results in heart disease and stroke” (p.1). 
Coronary heart disease (CHD), according to the National Heart, Lung, and Blood 
Institute (2016), “is a disease in which a waxy substance called plaque builds up inside 
the coronary arteries.  The condition is called atherosclerosis” (p.1). 
Dietary approaches to stop hypertension (DASH), according to the National 
Heart, Lung, and Blood Institute (NHLBI) (2016), “DASH is a flexible and balanced 
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eating plan that helps creates a heart healthy eating style for life.  The DASH eating plan 
requires no special foods and instead provides daily and weekly nutritional goals” (p.1).  
A well rounded DASH diet includes incorporating lean meats instead of fatty meats, and 
limiting soft drinks that are sweetened with sugar, and sweet treats.  The DASH diet 
should include healthy fats, and low fat dairy products.  Whole grains, fruits, and 
vegetables should be included in the DASH diet.  Foods high in saturated fat should be 
limited (NHLBI, 2016). 
Intima-media thickness (IMT), according to Simova (2015), “is a marker of 
subclinical atherosclerosis (asymptomatic organ damage) and should be evaluated in 
every asymptomatic adult or hypertensive patient at moderate risk for cardiovascular 
disease.  Intima-media thickness values of more than 0.9mm (ESC) or over the 75th 
percentile (ASE) should be considered abnormal” (p.1).  The two inner most layers of an 
artery are measured for thickness. 
Systolic blood pressure (SBP), according to Medicine Net (2016), “is specifically 
the maximum arterial pressure during contraction of the left ventricle of the heart” (p.1).  
The top number is systolic for a blood pressure reading.  The bottom number is diastolic 
blood pressure (DBP).  It occurs when the heart muscle is relaxing between beats. 
Theoretical Framework 
The Betty Neuman Systems model is the framework used to guide this study.  It 
conceptualizes a total body approach and is flexible in rapidly changing situations.  The 
model helps with identifying stressors.  Stressors can be physiological, psychological, 
developmental, sociocultural, and spiritual.  In correlation with the identified problem of 
coronary artery disease, the Betty Neuman Systems model can play a vital role with the 
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implementation of interventions to rectify identified stressors.  Patient stress level is of 
concern when certain procedures needed to correct a malfunctioning heart such as cardiac 
catheterization, oblation surgery, or coronary artery bypass graft surgery.  According to 
Parvan, Zamanzadih, Dizaji, Shabestari, and Safaie (2013),  
Neuman’s system model states that patients are an open system constantly 
interacting with their environment.  To ensure that the special needs of the patient are 
identified, this open system needs to have two-way communication at any time and a 
thorough assessment of the patient includes looking at all patient’s psychological, social, 
cultural, emotional, developmental, and religious variables.  Internal and external factors 
that interact with the client system are part of the environment.  The intrapersonal 
environment is the internal environment that includes influences within the system.  The 
external environment includes interpersonal and extra personal factors.  Stressors in the 
intrapersonal, interpersonal, and extra personal environment can influence the potential or 
actual reaction in the system, therefore, the main purpose of nursing is assessing the 
client to gain system stability through the attainment, retention, and maintenance of 
optimal health, and it is the nurse that creates a link among the client, environment, health 
and leads to the stability of the system (p.24-25).  
Primary prevention, secondary prevention, and tertiary prevention are all major 
factors in preventing cardiovascular disease in women.  Primary prevention helps in 
changing a person’s behavior, and reducing their risks to specific diseases.  Secondary 
prevention involves controlling the progression of the disease.  Through screening 
practices, there is detection of the underlying pathology changes affecting a person’s 
health.  Tertiary prevention provides a treatment plan to deal with the disease processes, 
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and the impact it has on the individual.  It is hoped to aid in sustaining quality of life.  
The goal of primary prevention is to reduce risks through life style changes, and modify 
behaviors, that could lead to developing a disease.  Diagnostic testing and screening of 
many health problems, can detect if a person has developed a health related issue.  
Through secondary prevention, the goal is to slow down further advancement of the 
disease, through cutting edge interventions.  Tertiary prevention promotes managing not 
only the illness of the individual, but also how the person is coping physically, mentally, 
and socially, (The Association of Faculties of Medicine of Canada, 2015). 
Evidence-Based Significance of the Problem 
Heart disease is the major cause of mortality for women in the United States.  
According to the Centers for Disease Control and Prevention (2016), “heart disease is the 
cause of death for women in the United States, killing 289,758 women in 2013-that’s 
about 1 in every 4 female deaths.  Almost two thirds (64%) of women who die suddenly 
of coronary heart disease have no previous symptoms” (p.1). 
Social Determinants 
It has been projected that by the year 2030, cardiovascular disease will be the 
leading cause of death in the United States.  According to Havranek et al. (2015), “the 
prevalence of CVD in the United States is expected to rise 10% between 2010 and 2030.  
This change in the trajectory of cardiovascular burden is the result not only of an aging 
population but also of a dramatic rise over the past 25 years in obesity, hypertension, 
diabetes mellitus, and physical inactivity that accompany weight gain” (p.873).  
Furthermore, “social determinants of health are the circumstances in which people are 
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born, grow, live, work, and age, and the systems put in place to deal with illness” 
(Havranek et al., 2015, p.874). 
Economic Factors 
Economic factors relating to cardiovascular disease is part of a system with many 
layers.  Regardless if an individual is of wealth, or low socioeconomic status, 
cardiovascular disease does not discriminate.  It does not matter what a person’s sexual 
orientation is, race, education level, culture, or demographics.  Economic factors relating 
to socioeconomic position is based on certain positions individuals hold in society, and 
the influence of having the means to control resources.  The rich can use their influence 
to control the political arena, by seeking to change policies in their own favor, and 
acquire resources, that further alienate the disadvantage.  Cardiovascular risk factors are 
deemed to be increased for poorly educated individuals, (Havranek et al., 2015). 
Implications for Social Change in Nursing Practice 
The field of nursing keeps evolving.  Leaders are emerging in the nursing field 
and the impact of nurses can be felt in all settings and disciplines.  Through secondary 
intervention, nurses play a pivotal role in ensuring patients are educated on acute and 
chronic conditions, and promoting ways to maintain optimal health.  Nurses have moved 
from beyond the bedside and have branched out to form collaborative bonds with other 
members of the interdisciplinary team.  The field of nursing is not only about providing 
care for the ill.  In the 21st century, nurses are responding to issues that involve business, 
technology, domestic, and global problems.  Nurses are seeking advanced practice 
positions, to further expand the roles of what nurses can do; whether it is exacting policy, 
or publishing a paper, (Tiffin, 2012). 
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Summary of the Practice Problem and the Project 
Little attention is paid to cardiovascular disease in women by practicing health care 
professional and patients.  Most women consider cancer as a grave concern and 
investigational studies have only focused on men.  The project is aimed to inform 
consumers and healthcare professionals about heart disease in women, the symptoms 
experienced, diagnosis, and interventions.  It is imperative that women learn to become 
more in tune with their bodies, to help recognize when something is wrong.  It remains an 
ongoing struggle for health professionals, to take the issue seriously, of women having a 
heart attack, because of the misconceptions differing in cardiac events among genders.  
Education is the only way to spread the news about cardiovascular disease in women.  
Health professionals have an obligation to engage others in fighting heart disease.  
Everyone has a voice to be heard, and all people have a right to advocate for their health.  
Women need sustainable treatments and guidelines. Regardless of a women’s age, she is 
susceptible to developing heart disease.  The risk is higher, if heart disease already runs 
in the family.  There is new research suggesting if women had complications during 
pregnancy with hypertension or diabetes, their children may be prone to developing heart 
disease subsequently. 
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Section 2: Review of Literature  
Introduction 
The projects goal is to help consumers and health professionals identify signs and 
symptoms of coronary artery disease in women, so appropriate treatment interventions 
can be implemented.  The purpose of the literature review is to analyze data from 
different nursing journals and publications looking for approaches of treating coronary 
artery disease in men and women, and learning if there are noticeable differences in the 
management and treatment between the genders.  A literature review of journal articles 
was conducted. Findings produced results on topics such as heart disease in women, 
gender differences in men and women with coronary artery disease, and cardiovascular 
disease in women. . 
Articles pertained to identifying differences in men and women with coronary 
artery disease were chosen and studies representing patient populations of individuals 
affected by coronary artery disease.  The goal of the review is to raise awareness for 
consumers and healthcare providers to educate women on their risk factors for 
developing coronary artery disease, heart disease consequences and treatment options. 
The following databases were researched for information: CINAHL plus with full 
text,  Cochrane, ProQuest Nursing & Allied Health Source, Medline with full text, and 
Google Scholar.  The following sources were used to identify coronary artery disease in 
women.  The literature was published between 2008 and 2014. 
1.  Cardiovascular Diagnosis & Therapy (2012) 
2. Circulation (2014) 
3. Clinical and Investigative Medicine (2014) 
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4. International Journal of Medicine (2014) 
5. Iranian Journal of Critical Care Nursing (2010) 
6. Journal of the American Medical Association (2008) 
7. National Heart, Lung, and Blood Institute (2010) 
8. New England Journal of Medicine (2014) 
9. Nurse Prescribing (2013) 
10. Nursing Research and Practice (2013) 
Coronary Artery Disease and Gender Differences 
Women are underrepresented when it comes to identifying cardiovascular risk 
factors.  Cardiovascular disease develops a decade later in women.  According to Maas & 
Appelman (2010), “cardiovascular disease develops 7 to 10 years later in women than in 
men and is still the major cause of death in women.  The risk of heart disease in women is 
often underestimated against cardiovascular disease.  The under-recognition of heart 
disease and differences in clinical presentation in women leads to less aggressive 
treatment strategies and a lower representation of women in clinical trials” (p.598). 
It is imperative for clinicians to recognize the differences in men and women’s 
hearts.  According to Jouria (2014), researchers from the University of Columbia and 
New York Presbyterian Hospital reported the following: 
While the area of study is somewhat new, it is a fact that women have smaller 
hearts and arteries than men.  It has been reported that women have different 
internal rhythm, which in general, causes a woman’s heart to beat faster than a 
man’s heart.  These researchers also believe that a woman’s heart may take longer 
to relax after each beat.  Additionally, some surgeons have hypothesized that 
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women have a 50% higher chance of dying during heart surgery compared with 
men and this may be due to the fundamental difference in the way a woman’s 
heart works (p.14). 
Unlike men, women who experience their first myocardial infarction tend to die 
after the attack versus a man.  According to Jouria (2014), “approximately 25% of men 
die within a year after their first myocardial infarction compared with 38% of women.  
Women are also approximately twice as likely to experience a second myocardial 
infarction within 6 years of the first myocardial infarction.  Additionally, women are 
approximately twice as likely as men to die after bypass surgery” (p.14). 
Women with high cholesterol and triglyceride levels, are at risk of  coronary 
disease in comparison to women with low density lipoproteins. A study called the 
Women’s Ischemia Syndrome Evaluation (WISE) highlighted that many women have 
undergone diagnostic tests, such as stress testing, and angiograms.  These tests did not 
pick up on issues, that women had significant blockages in their coronary arteries.  The 
diagnostic test appeared to be normal.  Women were symptomatic, experiencing chest 
pain.  There are new test, which involves the use of ultrasounds, which can detect 
problems missed from angiograms.  There have been problems trying to accurately 
pinpoint how a cardiac catheterization may show blood flow issues or myocardial 
ischemia, but stress testing yields no answers to a woman’s complaints of dyspnea or 
angina pain. 
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Section 3: Methodology 
Project Design 
The project design was a descriptive case series study.  The face sheets of thirty-
one patients were obtained; they present a description of the patients’ health complaints.  
The goal was to compare the male and female patients in the cardiology department 
presenting with angina pain to those without chest pain but other physical complaints, 
discovering how particular interventions are decided upon for these individuals.  Are the 
male patients undergoing invasive procedures, while the female patients are receiving 
more non-invasive modalities to diagnose coronary artery disease?  The data was 
collected quantitatively from the electronic medical record. Qualitative data were 
retrieved from the cardiology staff asking the patients’ questions.  Variables considered 
in the project are gender, obesity, hypertension, diabetes mellitus, elevated blood 
cholesterol, excessive coffee intake, smoking, and alcohol intake.  The theory to guide 
the study was Betty Neuman’s system model because it is a holistic model that is 
evidence-based and culturally sensitive to real world phenomena.  The models possible 
predictions for results are stronger assessments for identifying symptoms in diagnosing 
and managing coronary artery disease in women.   
Participants 
The participants were 31 cardiology patients ranging in age from 30-80.  Twenty-
two were female and nine were male.  The patients are regularly seen by the cardiology 
department at two large hospitals in the Northeast.  The cardiology staff receives consults 
from other physicians to evaluate patients.  It is routine to obtain the patient’s vital signs, 
during office visits.  An EKG is done to attain baseline information of what may be going 
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on with the heart.  The cardiologist or nurse practitioner asks the patients a battery of 
questions, trying to get to the root cause of their health complaints.  The cardiologist 
develops a plan of action that requires further investigation of the patient’s chest pain or 
syncope events.  The patients’ cardiac risks and patterns in disease processes are 
identified.  Interventions adhere to clinical practice guidelines for individuals with 
cardiovascular disease, and include engaging the patient in self-care modalities, such as 
monitoring of symptoms, medication adherence, and diet restrictions.  Interventions will 
hopefully help individuals manage and live with chronic illnesses to increase their quality 
of life. 
Materials 
Noninvasive testing was conducted to obtain an electrocardiogram (EKG), an 
echocardiogram (ECHO), stress testing, and wearing of a holter monitor.   
Sampling 
The purposive sample of clients was chosen by the preceptor.  Participants 
included 31 clients treated for heart disease from two hospital cardiology services in the 
Northeast.  Both men and women aged between 30 and 80 were included in the sample.  
Challenges presented were not having full access to clients’ medical records due to not 
being an employee of the clinical site.   
Instrumentation 
The instruments that were used in the study were electronic medical records and 
staff talking to patients to acquire data.  It was hoped that these instruments would assist 
in answering the project questions. 
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Instrument #1 Electronic Medical Records 
The electronic medical record (EMR) takes the place of a paper chart.  It provides 
a compilation of clinical data and medical history for patients under a provider’s practice.  
The electronic medical record is used for diagnosing and treatment.  According to Health 
IT (2014), the electronic medical record is more beneficial than paper charts for the 
following reasons:  
It allows providers to track data over time, identify patients who are due for 
preventive visits and screenings, monitor how patients measure up to certain parameters, 
such as vaccinations and blood pressure readings, and improve overall quality of care in a 
practice.  The information stored in EMR’s is not easily shared with providers outside of 
a practice.  A patient’s record might even have to be printed out and delivered my mail to 
specialists and other members of the care team (p.1).   
This instrument is the main source of information for the study.  It provides 
background history of the patient and a possible treatment plan.  The reliability and 
validity of the electronic health record needs more research.  There have been empirical 
studies on the electronic medical record for accuracy and completeness of data since the 
year 2004.  According to Chan, Weiner, and Fowles (2010), “the diversity among the 
studies made it hard to draw concrete conclusions.  Further research is needed to develop 
an evidence base to support the use of the electronic health record data in quality 
measurement focusing particularly on data attributes vital to quality measurement, such 
as granularity, timeliness, and comparability” (p.1). 
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Instrument #2 Interviews 
Interviews are a means of obtaining qualitative data to attain the meaning and 
story behind what is being presented by individuals.  Interviews are a more personal way 
of responding to others.  According to Valenzuela and Shrivastava,(2008)  
Interviews are completed by the interviewer based on what the respondent says.  
Interviews are a far more personal form of research than questionnaires.  In the 
personal interview, the interviewer works directly with the respondent.  Unlike 
with mail surveys, the interviewer has the opportunity to probe or ask follow up 
questions.  Interviews are generally easier for respondents, especially if what are 
sought are opinions or impressions.  Interviews are time consuming and they are 
resource intensive.  The interviewer is considered a part of the measurement 
instrument and has to be well trained in how to respond to any contingency (p.3). 
Instrument #3 The United States Census 
The United States (U.S.) Census provides data pertaining to all the residents in the 
United States and the economy.  The Census Bureau operates under two U.S. codes: Title 
13 and Title 26.  The mission of the U.S. Census is to protect the nation’s people through 
confidentiality, privacy, and sharing of work and skills globally.  According to the United 
States Census (2015), the goal is to “provide the best mix of timeliness, relevancy, 
quality and cost for the data collected and services” (p.1).  The United States Census has 
ongoing quality assurance programs to measure the validity and reliability of the data. 
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Instrument #4 The Centers for Disease Control and Prevention 
The Centers for Disease Control and Prevention (CDC) has a host of departments 
including data and statistics, diseases and conditions, traveler’s health, CDC jobs, as well 
as vaccines and immunizations.  The CDC is a federal agency and considered the top 
health institute for the United States.  Reliability and validity is not totally forth coming.  
According to Williams et al. (2009) “CDC reviewers acknowledge that reliability may 
sometimes have to be sacrificed for validity, especially in community-wide interventions, 
if they are to be ecologically valid” (p.222).  The CDC recruits experts from the medical 
profession and other fields to provide citizens with the necessary education to impact and 
fight against diseases, promote health, provide protection from injury and disability, and 
prepare for threats that can harm communities, plus populations nationally and globally. 
Instrument #5 Current Population Survey 
The current population survey is the number one source of labor force statistics for the 
population.  This survey offers quantitative data and is conducted by the United States 
Census Bureau for the Bureau of Labor Statistics.  According to the Bureau of Labor 
Statistics (2015), “the current population survey (CPS) is a monthly survey of households 
conducted by the Bureau of Census for the Bureau of Labor Statistics.  It provides a 
comprehensive body of data on the labor force, employment, unemployment, persons not 
in the labor force, hours of work, earnings, and other demographic and labor force 
characteristics. 
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Instrument #6 Townsend Deprivation Scores 
The Townsend Deprivation Scores was developed in the mid 1980s by a professor 
named Peter Townsend.  The primary focus is on material deprivation.  According to the 
University of Southampton School of Geography (2008), “the Townsend index is an 
area-based measure and can be constructed for any geographical area for which census 
data are available.  It has served both as a general measure of deprivation for academic 
studies of health care needs, educational achievement, and crime and also as an input to 
various resource allocation mechanisms intended to target resources to areas of greatest 
social need” (p.1).  There are four basic census variables (households without a car, 
overcrowded households, households not owner-occupied, persons unemployed).  These 
variables are divided by suitable household or person counts, which then yield a 
percentage score (University of Southampton School of Geography, 2008). 
Data Collection and Analysis Procedures 
 The general plan for how data were collected was through the electronic medical 
record, direct observation of procedures, and cardiology staff inquiring about the 
patients’ status. Data were provided to the student for content analysis of the 31 cases.  
Protection of Human Rights 
The confidentiality of patient face sheet information has not been compromised.  
The face sheets were kept in a secured binder with all identifiable demographics 
removed, and stored in my home office.  The face sheets were returned to Mercy Hospital 
of Philadelphia and given to a clinical preceptor for shredding on September 24, 2015.  
No identifiable information has been attributed to the patients.  The process of observing 
patients in the cardiology department undergoing assessments, procedures, discussing 
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medical history, and providing educational material involves minimal risk to human 
subjects.  Minimal risk is defined is defined by the National Institute of Health (2015), as 
a common rule to be that the probability and magnitude of harm or discomfort anticipated 
in the project are not greater in and of themselves than those ordinarily encountered in 
daily life or during the performance of routine physical or psychological examination or 
testing.  Most risk encountered by participants in projects fall into the following 
categories: physical, psychological, social, legal, and economics.   
Descriptive Studies 
Descriptive Studies help to describe patterns in disease, and relationships among 
variables such as to person, time, and place.  Descriptive studies provide information 
about populations or groups affected by disease.  It also establishes determinants for risk 
factors in decreasing disease. 
Case Series 
Case series is an outcome of interest.  The project’s outcome of interest is 
coronary artery disease.  Limitations of case series is that it cannot provide test validity 
statistical associations.  Advantages of case series help to develop new hypothesis. 
Significance of the Study 
Understanding the differences between how men and women are affected by heart 
disease will affect future projects.  Identifying the signs and symptoms of heart disease in 
women, will hopefully lead to early diagnosing of coronary artery disease.  Women need 
to participate in more clinical studies on heart disease, to ensure gender specific 
treatments, and obtain rationales through quantitative data, and surveillance. 
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Moreover, Aziz suggest (2014) that, the only way to fully understand coronary 
artery disease (CAD) in women, is to have research conducted, that is based off of 
gender.  The first line of prevention of CAD in women, involves behavior modification of 
being physically active, managing high blood pressure, decreasing tobacco, and 
consuming less alcohol.  Taking a baby aspirin daily, can help minimize the formation of 
blood clots, which can block an artery.  The use of hormone replacement therapy in 
treating CAD is not well established; more research is needed. Women are at an 
increased risk of having a heart attack or stroke, when the amino acid called 
homocysteine is elevated.  This amino acid is responsible for protein metabolism.  The 
use of folic acid may provide some benefit in decreasing homocysteine levels.  Women 
with high levels of cholesterol, may benefit by incorporating fish oils in their diet, such as 
Omega-3 fatty acid.  Randomized controlled trials on the use of antioxidant supplements, 
in managing CAD, showed not benefits. 
Over the years, there have been several crusades, promoting heart health 
initiatives for women.  One of the main problems women face is not being informed by 
their primary practitioners, that they possibly have more than one risk factor, for 
developing heart disease.  Most women at their doctor’s office visit, have their weight 
taken.  They are possibly informed, that they should shed a few pounds, and that is 
basically it.  No wonder why many women have no idea, to have their hearts examined.  
Practitioners must be vigilant to continuously monitor patients’ blood pressure, 
cholesterol levels, and blood sugars (CardioSmart, 2016). 
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Section 4: Findings, Discussion, and Implications 
Case Scenarios 
Thirty-one patients were asked impact questions by the cardiology staff in order 
to evaluate their risk assessment.  The questions asked of patients included: 1) Have you 
ever experienced a heart attack? 2) Do you have a history of cardiomyopathy? 3) Does 
your mother, father, or siblings have a history of heart disease? 4) Have you ever 
experienced a stroke? 5) Do you smoke cigarettes? 6) Do you drink alcoholic beverages? 
7) Do you limit salt in your diet? 8) Do you exercise? 9) What is the nature of your visit 
to the office?  The patients will be referred to as patient A through patient Z; patient AA 
through EE.  Risk profiles are presented for each of the patients. 
Patient A:  Patient is a 59-year-old female who presents for risk of stratification 
for upcoming lung cancer surgery.  The patient complains of chest discomfort.  The 
patient describes the pain as tightness.  There are no significant aggravating factors.  The 
patient states nothing seems to relieve the pain.  The discomfort occurs at rest, at night, 
and more frequently with movement.  The patient’s risk factors are diabetes, 
hypertension, and smoking.  The patient has an EKG test.  The rhythm is sinus with 
undetermined age septal myocardial infarction.  The patient will undergo a myocardial 
perfusion study/Bruce protocol and 2 D Echocardiogram. Patient states a family history 
of heart disease.   
Patient B: Patient is a 31-year-old female who presents with left heart failure due 
to peripartum cardiomyopathy, postpartum condition, or complications.  The patient’s 
heart failure is NYHA classification I, AHA/ACC Stage C (New York Heart 
Association/American Heart Association/American College of Cardiology). Stage C 
26 
 
refers to patients who have developed clinical heart failure.  Risk factors are former 
tobacco usage.  The patient is wearing a LIFE vest in the event that an arrhythmia is 
detected.  The LIFE vest has a defibrillator implanted inside.  There is no family history 
of heart disease. 
Patient C: Patient is a 63-year-old female who presents for congestive heart 
failure, pulmonary hypertension, hypertension, and hyperlipidemia.  The patient recently 
experienced a hypoxemia episode.  The patient is on home therapy of 2 liters of oxygen 
via nasal cannula.  The patient wears a CPAP machine at night for obstructive sleep 
apnea.  Risk factors are hypertension and diabetes.  The patient will have an EKG and 
echocardiogram performed. 
Patient D:  Patient is an 84-year-old female being evaluated for syncope.  The 
patient complains of feelings of light headedness.  The patient states symptoms began 4 
months ago.  The symptoms usually occur after standing (from sitting).  The symptoms 
are relieved by sitting.  The patient does not report a history of alcoholism.  The patient 
has a history of coronary artery disease, fatigue, headaches, ischemic cardiomyopathy, 
myocardial infarction, seizures, stroke and visual changes.  The patient has a past history 
of hypertension, hyperlipidemia, and gastroesophageal reflux disease, arthrocentesis of 
the right knee joint, cholecystectomy, and hysterectomy.  The patient denies orthopnea, 
dyspnea on exertion, or edema.  The patient denies claudication.  The patient has no 
symptoms attributable to valvular heart disease.  The patient will have a 2 D 
echocardiogram, and an ankle-brachial index will be performed. 
Patient E: Patient is a 45-year-old female.  Presents with chest pain and 
hypertension.  The patient complains of chest discomfort.  The discomfort is located in 
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the substernal area and radiates to the left arm.  The patient describes the pain as sharp 
and tightness.  The discomfort occurs at rest.  Pain starts in the left arm and radiates to the 
chest and lasts for one minute.  The patient has a strong history of coronary artery 
disease.  The patient has high blood pressure, high salt intake, and obesity.  Negative 
symptoms include dyspnea, headache, nausea, tinnitus, transient weakness, visual 
disturbances, vomiting, and diaphoresis. The patient will have a myocardial perfusion 
study performed with Bruce protocol. The patient is scheduled for a 2 D echocardiogram 
and is advised to follow a low-salt and low-fat diet. 
Patient F: The patient is a 74-year-old female.  The patient complains of chest 
discomfort located in the epigastric area.  The pain does not radiate.  The patient 
describes the pain as pressure and states that walking makes it worse.  The pain is 
relieved with rest.  The discomfort occurs with exertion and the patient states having two 
episodes in the last month.  The patient has hypertension.  Comorbid conditions include 
diabetes mellitus.  Pertinent negative symptoms include diaphoresis, nausea, dyspnea, 
and transient weakness.  The patient also has dyslipidemia and states being a former 
tobacco user of ten cigarettes per day.  The patient is scheduled for a 2 D echocardiogram 
with color flow Doppler. Diet issues discussed with the patient; a stress test for 
myocardial perfusion using Bruce protocol is planned. 
Patient G: The patient is a 51-year-old female who presents with chest pain, 
CAD, and hypertension.  The patient states having chest discomfort that is located in the 
substernal area.  The patient describes the pain as tightness and states exertion makes it 
worse.  The pain is relieved with rest.  The patient has a history of hypertension and 
medications are an ACE inhibitor Lisinopril 40mg, aspirin therapy, and a Beta Blocker 
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Atenolol 25mg.  The patient is scheduled for a myocardial perfusion study with 
Dipyridamole protocol.  The patient will have a left and right cardiac catheterization 
performed.  The patient is advised to follow a low-fat and low-salt diet. 
Patient H:  The patient is a 57-year-old female presenting with cardiomyopathy, 
hypertension, and hyperlipidemia.  The patient states that she has had multiple cardiac 
work ups including echocardiograms, stress test, and cardiac catheterization. The patient 
states that she has been informed that her heart is weak.  There are no complaints of chest 
discomfort. The patient uses a walker to assist with ambulation.  The patient states that 
inactivity led to obesity and depression.  The patient will have a persantine stress test 
performed.  The patient is being screened for hypertension.  Denies alcohol and use of 
tobacco. 
Patient I: The patient is a 43-year-old female who presents with cardiomyopathy 
and is trying to obtain surgery clearance.  The patient had an echocardiogram performed 
and was diagnosed by one of the cardiologist as having severe cardiomyopathy.  The 
patient has dyspnea on exertion and is only able to walk one flight up the stairs despite 
her young age. Patient denies chest pain or discomfort.  Patient states that she sometimes 
has intermittent lower extremity edema.  The surgery clearance is needed for the patient 
to undergo a dilation and curettage test (D&C) as well as hysteroscopy.  The cardiologist 
decided to delay the patient’s surgery for now and perform an extensive cardiac work up 
to evaluate why the patient has severe cardiomyopathy.  Patient is a smoker of cigarettes 
and states she is trying to decrease usage of the product.  The patient is counseled on 
incorporating a low-fat diet. 
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Patient J: The patient is a 54-year-old female who presents with A Fib, 
hypertension, and congestive heart failure.  The patient has paroxysomal atrial 
fibrillation.  Her symptoms with the arrhythmias have included palpitations.  The 
CHADS2 recommendation scoring is incomplete.  The patient’s last known ejection 
fraction was 0.30.  The patient’s comorbid conditions include hypertension and heart 
failure. The patient experiences chest pain, claudication, confusion, diaphoresis, 
epistaxis, fatigue, headache, hematuria, nausea, tinnitus, transient weakness, visual 
disturbances, and vomiting.  The patient has a dependence on opioids.  The patient has an 
implantable chest wall device.  The patient will have the device removed from the chest 
wall.  The patient would like the device removed because it is irritating and no episodes 
of heart arrhythmias have occurred. The patient has a history of chronic systolic heart 
failure and benign essential hypertension.  Laboratory work will be ordered for the 
patient; BMP, CBC, PT, and PTT.  The patient is advised to follow a low-sodium diet.  
The plan for the patient will involve having a 2 D echocardiogram and a falls risk 
screening. 
Patient K: The patient is a 69-year-old female who presents to the cardiology 
department for valve clinic evaluation.  The valve team includes the cardiothoracic 
surgeon, valve coordinator, nurse practitioner, and cardiology staff.  The patient has 
valvular heart disease.  The patient complains of dyspnea on exertion, feeling tired, and 
lightheadedness on exertion.  Patient denies any syncopal events.  The patient is being 
evaluated for shortness of breath and states that her inability to get air into the lungs is 
compromised further after the climbing of one flight of stairs.  Relieving factors include 
rest.   The patient is scheduled for a pulmonary consult.  Patient has sleep apnea and is 
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encouraged to be compliant with CPAP machine.  The patient continues to smoke 
cigarettes. She is counseled on tobacco cessation and is advised to follow a low-sodium 
diet because of a history of benign essential hypertension.  The patient is well controlled 
on medical therapy.  The patient has a psychological consult to discuss anxiety; it has 
been recommended for the patient to take Buspirone medication. 
Patient L: The patient is a 32-year-old who presents with an abnormal 
electrocardiogram (ECG) and needs surgery clearance for bariatric treatment.  The patient 
is morbidly obese; they are advised to follow a low-fat diet.  The ECG is nonspecific 
showing abnormalities in the ST and T wave segments.  The patient needs further cardiac 
evaluation.  Stress test using Bruce protocol is ordered along with a stress 
echocardiogram. 
Patient M: Patient is a 55-year-old female who recently had a transthoracic 
echocardiogram.  The findings show global left ventricular wall motion and that 
contractility is normal.  The ejection fraction is estimated at 50-55%.  There is evidence 
of moderate pulmonary hypertension.  The right ventricular systolic pressure is calculated 
at 44mmHg.  There is mild tricuspid regurgitation.  The patient had bariatric surgery in 
March of 2014; past weight was 292lbs and current weight is 164lbs. 
Patient N: The patient is a 69-year-old female who presents with palpitations and 
hypertension.  Comorbid conditions include diabetes mellitus.  Associated symptoms 
include irregular heartbeat.  Pertinent negatives include chest pain, claudication, 
confusion, diaphoresis, dyspnea, epistaxis, fatigue, headache, hematuria, nausea, tinnitus, 
transient weakness, tremor, visual disturbances, and vomiting.  There is a family history 
of CAD.  The patient has benign essential hypertension that is inadequately controlled.  
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Cardiologist will add 60mg Diltiazem for AM and 240 mg Diltiazem at mid-day.  A 2 D 
w/CFD echocardiogram ejection fraction will be performed.  The patient is advised to 
follow a low-sodium diet. 
Patient O: The patient is a 49-year-old female who presents for a follow-up 
appointment for pulmonary hypertension.  The patient is a former tobacco user.  The 
patient had an echocardiogram performed.  The findings showed mild mitral 
regurgitation.  The pulmonologist performed a pulmonary function test; findings showed 
small vessel disease.  The patient is a bariatric candidate.  The patient is advised to 
exercise and adopt healthy food choices.  The patient will see a cardiologist in 6 months. 
Patient P: The patient is a 72-year-old female who presents with dyspnea and 
hypertension.  For a couple of months the patient has been experiencing shortness of 
breath and fatigue.  Pertinent negative findings include anxiety, chest pressure, stridor, 
and substernal chest pain.  The patient states feeling very short of breath after walking 
one block.  During a physical examination, it was discovered that the patient has a 
murmur.  The patient is scheduled for a 2 D w/CFD echocardiogram before next visit 
with the cardiologist.  ECG findings show T wave inversions in anteroseptal leads with 
symptoms of dyspnea.  Lexiscan myocardial perfusion imaging (MPI) will also be 
performed before the next cardiology visit.  The patient has chronic obesity.  The patient 
is advised to follow a low-fat and low-sodium diet.  No changes to medications. 
Patient Q: The patient is a 73-year-old female who presents with shortness of 
breath and abnormal EKG.  The patient had a myocardial perfusion imaging test 
performed after radiology administered intravenous of 10.1 mCi Tc 99m SESTAMIBI 
prior to the resting images, and 30.2 mCi Tc 99m SESTAMIBI prior to the stress images.  
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Finding show there is no fixed transient perfusion defects. Gated wall motion images 
were performed with patient in post stress state.  Left ventricular ejection fraction was 
80%.  End-diastolic volume was 53ml.  End-systolic volume was 10ml.  There were no 
regional wall motion abnormalities.  The patient was tested utilizing IV Dipyridamole 
protocol.  The patient was given by radiology, 51.8 mg of Dipyridamole diluted in 20.6 
cc of normal saline.  The solution was given intravenously slowly over 4 minutes.  Initial 
blood pressure was 124/76.  Final blood pressure was 120/70.  EKG showed no 
suspicious ST changes.  The study was reviewed with the attending radiologist. 
Patient R:  The patient is a 78-year-old female who presents for a follow-up 
appointment for CAD.  The patient initially presented with acute coronary syndrome.  
The patient presented with shortness of breath and shortness of breath on exertion.  The 
patient is currently on the following: ACE inhibitor Quinapril 40mg, aspirin and other 
anti-thrombotics, Beta Blocker carvedilol 3.125mg for left ventricular systolic 
dysfunction (LVSD), and lipid lowering Simvastatin 20mg.  The patient rates shortness 
of breath as moderate to severe.  The patient qualifies the shortness of breath as inability 
to get air into the lungs.  The symptoms worsen with normal routine activities, such as 
walking, bathing, eating, and dressing.  Relieving factor includes rest. The patient will 
receive full cardiac work up: coronary computed tomography angiogram, pulmonary 
function test, and ambulatory pulse oximetry.  The patient has multivessel CAD.  The 
patient is advised to follow a low-fat diet. The patient has benign essential hypertension. 
Referral to pulmonary medicine for pulmonary functions test and diffusion capacity. The 
patient has chronic obesity.  No changes to medications.  Cardiology to discuss benefits 
and risks of having a coronary artery bypass graft performed (CABG). 
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Patient S: The patient is a 66-year-old female with chest pain and hypertension.  
The patient complains of chest discomfort in the substernal area.  It radiates to the left 
arm and under the left breast.  The patient describes the pain as pressure and states meals 
makes it worse and lasts for a few seconds.  Pertinent negative symptoms include 
diaphoresis, dyspnea, and nausea.  The patient is counseled on a low-salt and low-fat diet.  
The patient is encouraged to exercise; patient has chronic obesity.  Before the next visit 
with the cardiologist, the patient is scheduled to have a 2 D w/CFD echocardiogram and a 
myocardial perfusion study with Dipridamole protocol.  The patient also counseled on 
how to take blood pressure with digital cuff and keep a blood pressure diary. 
Patient T:  The patient is a 65-year female who presents for surgery clearance for 
bariatric treatment.  The patient is being considered for gastric bypass surgery.  The 
patient does not have any active cardiac conditions such as unstable angina, recent 
myocardial infarction, decompensated heart failure, significant valvular disease, or 
significant arrhythmias.  The patient walks with a walker and has musculoskeletal 
complaints.  The patient has hypertension and chronic obesity.  EKG is suggestive of 
possible septal infarct.  The plan is for the patient to have a 2 D echocardiogram and 
nuclear stress test with Dipyridamole MPI before the next visit with the cardiologist.  The 
patient is encouraged to exercise and counseled on lifestyle education regarding diet. 
Patient U: The patient is a 58-year-old female who presents for evaluation for 
CAD. The patient recently had an acute myocardial infarction. The patient is being 
evaluated for systolic heart failure due to other specified forms of chronic ischemic heart 
disease.  Pertinent negative symptoms include chest pain, claudication, smoking, 
confusion, diaphoresis, epistaxis, and headaches.  The patient states chest pain is 
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moderate and occurs daily.  Discomfort is located in the precordial area and radiates to 
the left arm.  The patient undergone a procedure to help treat the narrowing of the 
coronary arteries, called percutaneous coronary intervention.  The anticoagulant 
medication Brilinta was instrumented..  The patient ejection fraction is 35% and meets 
the criteria for a primary prevention implantable chest device (ICD). The patient is 
scheduled for further cardiac evaluation.  Coronary angiography findings show coronary 
atherosclerosis of naïve coronary artery. The patient is advised to follow a low-fat and 
low-salt diet.  The patient continues to smoke and is counseled on tobacco cessation.  The 
patient is scheduled for a myocardial perfusion study test using Bruce protocol.  The 
patient is also scheduled for a 2 D echocardiogram. The patient has benign essential 
hypertension and is adequately controlled on ACE inhibitor lisinopril 5mg, and Beta 
Blocker carvedilol 12.5mg for LVSD. 
Patient V: The patient is a 79-year-old female with risk factors of peripheral 
vascular disease, dyslipidemia, hypertension, and tobacco usage.  The patient had an 
acute myocardial infarction two years ago with ST elevation (STEMI).  A cardiac 
catheterization was performed and a stent was placed by cardiology.  The patient has a 
large severe perfusion defect in the lateral wall, extending partly into the inferior and 
anterior walls of the heart with near complete reversibility at rest with moderate 
hypokinesis of the anterolateral walls.  ECG shows ST ischemic changes. 
Patient W: The patient is a 55-year-old male who presents with complaints of 
weakness.  The patient experiences centrally located chest discomfort that radiates to his 
left jaw and arm.  He states his symptoms of weakness are localized to his left side of his 
body.  The patient has had a stroke in the past.  The patient takes a sublingual 
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nitroglycerin tablet for his chest discomfort.  The patient has an implantable chest device 
(ICD) and denies any recent discharge from the device.  The patient has a past medical 
history of ventricular tachycardia arrest leading to the implantation of his Biotronik ICD 
which is a single-chamber device.  The patient has a history of pulmonary embolism as 
well as prostate cancer.  The patient states he has been treated in the past with 
chemotherapy for several months. The prostate cancer has returned and now he has a 
chemotherapeutic implant.  There is no history of hypertension or myocardial infarction.  
The patient has had a cardiac catheterization in the past with no intervention.  There is a 
history of dyslipidemia.  The patient has a Greenfield filter placed for an implantable 
cardioverter defibrillator.  The patient does not smoke, drink, or indulge in illicit drug 
use; he has quit abusing cocaine.  The patient states having a family history of coronary 
artery disease.  The patient is scheduled for a 2 D echocardiogram and pharmacologic 
stress testing.  ICD will be interrogated.  
Patient X:  The patient is an 81-year-old male presenting with coronary artery 
disease and hypertension.  The patient experienced an acute myocardial infarction.  Risk 
factors are diabetes, hypertension, and dyslipidemia.  An echocardiogram and EKG is 
performed.  EKG shows pre-ventricular contractions and sinus bradycardia.  The patient 
had an undetermined age anteroseptal myocardial infarction.  The patient has multi-vessel 
coronary artery disease.  He is not a candidate for coronary artery bypass graft (CABG).  
The patient is to wear a LIFE vest until left ventricular systolic function is evaluated. 
Patient Y:  The patient is a 61-year-old male presenting with respiratory and 
throat pain.  The patient complains of shortness of breath and sore throat for a couple of 
hours.  The patient states having a mold problem in the home.  Patient states, “I cannot 
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breathe.”  The pulse oximetry on room air was 18.  Patient has a past medical history of 
diabetes, hypertension, reflux disease, diabetic neuropathy, and human 
immunodeficiency virus.  The patient is morbidly obese.  The patient has obstructive 
sleep apnea but does not wear a mask stating he is claustrophobic.  The patient denies 
smoking and consuming alcohol but does admit to using marijuana.  The patient states no 
family history of early coronary artery disease.  The patient had a cardiac catheterization 
last year.  The patient is to be evaluated by the pulmonology department, and have a CAT 
scan of the chest. 
Patient Z: The patient is a 53-year-old male presenting with an abnormal EKG.  
Patient has risk factors of hypertension, obesity, and tobacco use.  The patient had a 
recent stroke with left side weakness; walks with a cane.  EKG shows mild depressed left 
ventricular function and T wave inversion in inferior and lateral leads.  The patient states 
that in 2009 a cardiac catheterization was performed after experiencing a myocardial 
infarction.  The patient will have a myocardial perfusion study performed with 
Dipyridamole protocol. 
Patient AA: The patient is a 50-year-old male who left the hospital against 
medical advice (AMA) but was readmitted the next day after collapsing when walking 
for one block.  The patient is in detox treatment for heroin abuse.  A medic brought the 
patient to the emergency room; he was then transferred to the critical care unit.  The 
patient went into cardiogenic shock and suffered a non ST elevated myocardial infarction 
(NSTEMI). The patient presented with pulseless electrical activity (PEA) but eventually 
there was return of spontaneous circulation (ROSC).  The patient was stabilized and sent 
for a cardiac catheterization the following day.  Findings reveal that the left anterior 
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descending artery is blocked and not amenable to intervention.  The patient was 
scheduled for ICD placement but left again AMA. 
Patient BB: The patient is a 66-year-old male who needs a consultation for risk 
stratification for endoscopy.  The patient was admitted to the facility for gastrointestinal 
bleeding.  The patient has a history of hypertension, chronic renal insufficiency, and is 
dialysis dependent.  He also has a history of diabetes, paroxysmal atrial fibrillation, and 
depressive cardiomyopathy with ejection fraction known to be around 10 %.  The patient 
has a history of coronary artery disease but has not required percutaneous intervention.  
The patient has no family history of early CAD.  While the patient was hospitalized, he 
was treated for septic shock as a result of ischemic bowel.  He has undergone partial 
small bowel resection. Echocardiogram reveals aortic stenosis.  The patient has a remote 
smoking history; denies the use of alcohol or indulge in illicit drugs.  The patient has an 
implantable chest device called Boston Scientific Biventricular implantable cardioverter-
defibrillator.  Cardiology suggests that the patient is a low risk for endoscopy procedure 
but should be guarded against hypotension during sedation considering his aortic 
stenosis. 
Patient CC: The patient is a 59-year-old male who presents to the facility after 
having an argument with someone the same day.  The patient states having chest pain, 
and shortness of breath along with palpitations.  He also states feeling dizzy but has not 
lost consciousness.  Developed tingling and numbness on right side of face and right 
upper extremity.  The patient has a medical history of diabetes mellitus, hypertension, 
chronic obstructive pulmonary disease (COPD), peripheral neuropathy, and cerebral 
vascular accident (CVA). The patient has a loop monitor implanted for arrhythmias. 
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There is a family history of diabetes mellitus.  Admits to smoking cigarettes and uses 
cocaine recreationally. Plan of action for patient is to rule out a stroke relating to right 
side numbness, monitor chest pain related to emotional stress, and manage chronic 
problems of diabetes mellitus and COPD. 
Patient DD: The patient is a 56-year-old male who presents with 
cardiomyopathy, congestive heart failure, and hypertension.  The patient was seen by 
cardiology for chronic systolic heart failure due to other primary cardiomyopathies.  The 
patient’s heart failure is NYHA classification I, AHA/ACC Stage C.  The patient is 
currently on the following: ACE inhibitor lisinopril 20mg, Beta Blocker Therapy for 
LVSD carvedilol 25 mg, loop diuretic furosemide 40mg, and warfarin Coumadin 5mg.  
The patient has a history of hypertension and dyslipidemia including comorbid conditions 
of heart failure and stroke.  The patient’s ejection fraction is 35%.  Scheduled for a 2 D 
w/CFD echocardiogram, ejection fraction, and myocardial perfusion study with Bruce 
protocol.  The patient is advised to follow a low-salt diet and to cease smoking.  The 
patient is given educational material on congestive heart failure. 
Patient EE: The patient is a 58-year-old male with past medical history of 
hypertension, dilated cardiomyopathy with left ventricular ejection fraction of 26%, and 
saddle embolus/bilateral pulmonary emboli. The patient has a massive CVA and has 
undergone extensive physical therapy. Admitted to facility for atypical chest pain and 
shortness of breath. Ventilation/perfusion scan (VQ) showed recurrent pulmonary 
embolism.  A pulmonologist was consulted and the patient was admitted as an inpatient 
to the facility.  The patient was started on a heparin drip and Coumadin. The patient is 
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clinically stable with an international normalized ration (INR) of 2.5.  The patient will be 
discharged to home with physical therapy. 
Discussion of Findings 
By the year 2030, it is estimated that the cost of caring for a person with the 
medical conditions of stroke, heart failure, high blood pressure, heart disease, and other 
forms of cardiovascular disease, will be well over $800 billion.  The populations most 
affected by the burden of disease, disability, and barriers to healthcare, are minority 
communities, and those of low socioeconomic status (Heidenreich et al, 2011). 
The risk profiles for each patients had one or more risk factors for diabetes, 
hypertension, smoking, and dyslipidemia,  A few patients abused illegal drugs; 
specifically cocaine, heroin and marijuana. 
Women who may experience having a heart attack, have symptoms that are 
unconventional.  Some women may not have any symptoms, while others may have 
lower back pain, nausea, vomiting, jaw pain, extreme tiredness, a full feeling, and angina 
pain.  So many women are dying on a yearly basis from heart attacks, which never had 
any warnings. 
Upon experiencing a stroke, there may be noticeable asymmetry of the face, 
slurred speech, difficulty moving extremities, difficulty speaking or comprehending, 
trouble breathing, loss of motor functions, the worse possible headache, blurred vision, or 
passing out. 
The cardiology practitioners at Mercy Hospital of Philadelphia manage and 
sustain many patients with medication regimens.  Beta blockers, Ace-inhibitors, 
anticoagulant therapy and diuretics, all play a crucial role in managing heart disease. 
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A study was conducted in France in August 2015 discussing deprivation in 
relation to individuals having a higher morbidity and mortality due to inequalities in 
healthcare.  The study combined three measurements of deprivation (EPICES Scores, 
Townsend Index, and Carstairs Index), to compare social characteristics, indicators of 
morbidity, health-care use and mortality, and specific causes of death.  According to 
Labbe et al. (2015), 
The Pearson correlation coefficients were calculated to assess the reliability of the 
EPICES score.  The association between deprivation and mortality was assesses 
by comparison of the standardized mortality ratio (SMR) between the most and 
least deprived districts.  The results of the study showed EPICES scores are 
strongly correlated with the Townsend and Carstairs Indexes and with the health 
indicators measured.  SMR increased with deprivation, and the higher the 
deprivation the higher the SMR for all-cause mortality, premature, and avoidable 
deaths and for most specific-causes of death.  Deprivation is a determinant factor 
that should be considered systematically by health policy makers and health-care 
providers (p.604). 
There are new updated guidelines for primary prevention of stroke.  In the United 
States, over 700,000 individuals are affected by stroke.  Many people are left with severe 
neurological deficits, motor impairments, and sensory deficits.  Individuals who are 65 
years of age or older, may need help with managing every aspect of their lives, after 
suffering a debilitating stroke.  Close to 70% of strokes are first time events.  Strokes can 
be hemorrhagic, where a blood vessel may burst, or there is leaking of blood from the 
vessel.  Strokes can also be ischemic, where a blood vessel is blocked with calcium 
41 
 
buildup.  The use of a stroke risk calculator may provide valuable information, in hopes 
of preventing a stroke.  Nearly 80% of strokes are preventable. 
Health practitioners should consider screening tools, such as carotid artery testing, 
along with peripheral, arterial, and venous systems testing, for those individuals who 
have parents, siblings, grandparents, aunts or uncles, who have experienced a stroke.  
Exercise is beneficial to stroke prevention; at least 30 minutes of physical activity a day.  
The stroke risk calculator is a tool to predict a person having a stroke within 10 years.  It 
is used for people within the age groups of 55-85.  The risk calculator ask questions 
pertaining to gender, race, total cholesterol values, high density lipoprotein values, 
systolic and diastolic blood pressure readings, and treatments for high blood pressure.  
Other questions involve asking if the person is a diabetic, and a smoker. 
Statins and aspirin therapy are used for primary prevention of strokes.  These 
medications can cause side effects, and the use of them must benefit the person, and 
outweigh harm.  The use of the vitamin Niacin may raise the good cholesterol levels, but 
stroke prevention has not been validated with this vitamin.  The vitamin Folic Acid 
supplementation may be effective in preventing strokes. 
Uncontrolled high blood pressure can lead to high volumes of blood coursing 
through and hitting the sides of the artery walls.  Maintaining a systolic pressure below 
140mmHg and a diastolic pressure below 90 is ideal, along with implementation of 
antihypertensive medications.  Teaching patients how to monitor their blood pressure is 
beneficial.  A home blood pressure monitor, will help patients track their numbers. 
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Obesity places a great burden on the body.  Obesity increases stroke risk, despite 
a individual having other known risk factors for cardiovascular disease.  Weight 
reduction will help decrease blood glucose levels, and blood pressure. 
There are three new anticoagulant medications on the market to treat strokes and 
heart attacks.  Pradaxa (Dabigatran), Xarelto (Rivaroxaban), and Eliquis (Apixaban), all 
are used to prevent strokes and blood clots in people that have atrial fibrillation, which is 
not caused by a heart valve problem.  Pradaxa comes with risks of possibly causing a 
heart attack, and intestinal bleeding. 
The Cotswold Heritage and Detecting Society (CHA2Ds2-Vasc), have developed 
a scoring system for people with conditions such as congestive heart failure, 
hypertension, and diabetes.  The person’s age is factored into the scoring.  The results of 
the scoring, can predict a person’s risk of having a stroke, from non-rheumatic atrial 
fibrillation, causing a thromboembolic stroke, and dangerous heart rhythms. 
The CHA2Ds2-Vasc score will determine if a patient should receive aspirin or 
other anticoagulant medications.  The recommended dose of aspirin therapy is 81mg 
daily.  Individuals who have the medical condition sickle cell anemia, and are at risk for 
having a stroke, a noninvasive ultrasound called a transcranial doppler can be 
incorporated.  The ultrasound can measure how fast blood flows in the brain.  Patients 
who have a history of blood clots, and mitral valve stenosis are candidates for receiving 
anticoagulant therapy.  Aspirin therapy is beneficial for individuals with artificial heart 
valves, to prevent strokes.  Patients with a certain percentage of having a blocked carotid 
artery, but does not experience any complications or symptoms, are candidates for aspirin 
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and statin management.  The older people advance in age, the more prone they become to 
experiencing a stroke. 
Women that suffer from migraines with auras, are at an increase risk for having a 
stroke.  Women should not smoke, who have migraines.  If sexually active, these women 
need to switch to a contraceptive method, other than oral contraceptives (Anderson and 
Vega, 2015).    
Disease monitoring of the heart involved performing several test; 
electrocardiogram (EKG), echocardiogram, stress testing, and cardiac catheterization.  
The EKG provides results of how the heart’s electrical conduction system is functioning.  
The heart’s rhythm can be measured.  A baseline EKG is usually obtained on patients 
with complaints of chest pain or heart palpitation.  Further investigation of the heart 
vessels and structures, may warrant the use of a test called an echocardiogram.  The 
heart’s action can be displayed, from the ultrasound waves that are produced.  A 
transesophageal echocardiogram (TEE), is another type of echocardiogram.  The patient 
is sedated for this procedure.  Medication is administered intravenously.  A bite block is 
placed in the mouth, and a lubricated thin tube, called an endoscope, is passed down the 
esophagus to the stomach.  The endoscope has an ultrasound transducer attached, where 
pictures of the heart and arteries can be taken. 
Health practitioners may want to see how the heart operates under stress.  
Physical activity of walking on a treadmill, will provide the heart’s rate and rhythm, 
while the blood pressure, and respiratory rate are also monitored.  The test can reveal 
heart problems, which may not be noticeable with other diagnostic test.  Exercising on a 
treadmill, may prove to be too much for some people.  Another way to stress the heart, is 
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with the use of chemical agents that will make the heart pump and beat fast, as if the 
person is actually physically exercising.  The pharmacologic agent normally used for the 
test is called Persantine.  This agent is administered intravenously with an isotope, which 
highlights the damaged areas of the heart by radiography.  Coronary artery disease can be 
diagnosed with stress testing. 
If plaque is blocking an artery, or if the artery is narrowed, a cardiac 
catheterization test can definitively show what blood vessels of the heart are blocked.  A 
cardiac catheterization can  be performed, when a person is acutely experiencing a 
myocardial infarction.  Cardiac catheterization, along with angioplasty, can be performed 
to unblock clogged arteries (Jouria, 2015). 
Implications 
Policy: Heart disease and stroke are two preventable diseases. Five years ago, the 
Centers for Disease Control and Prevention initiated a public health response action plan 
to strategize preventing heart attacks and strokes. 
Practice: Nurses are skilled and proficient to lead and manage CVD in the 
community, hospital settings, and outpatient clinics.  Nurses understand the diversity of 
populations based on literacy, sociodemographics, ethnicity, race, and culture.  Advanced 
practice nurses with the assistance of using a cardiovascular risk assessment tool for 
women can help with implementing education and counseling to women regarding 
maintaining a healthy weight, smoking cessation, physical exercise, stable blood pressure 
and cholesterol levels, improved diet, managing stress and mood, as interventions for 
managing coronary artery disease.  The cardiologist and advanced practice nurse screens 
patients, and provides education and counseling.  Upon identifying the patients’ risks, 
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tests are scheduled that may include a physical stress test, wearing a Holter monitor for 
48 hours, and having an echocardiogram performed.  Once information from these test 
are received, the cardiology staff can determine if medication management or invasive 
testing is warranted.  The cardiologist and nurse practitioner schedule follow-up 
appointments after 6 months and make routine telephone calls to patients.  Patients that 
are on warfarin anticoagulant therapy will have their INR results discussed and levels 
adjusted as needed.  Patients can always call the cardiology office with questions and 
concerns, or if they need to be seen sooner than a regular scheduled appointment. 
Project: The Agency for Healthcare Research and Quality supports a research 
program on cardiovascular disease and chronic illness in women. 
Social Change: Social change helps to shape our development, growth, and 
identity.  Health and society are intertwined.  Regardless of race, color, or creed, all 
human beings have the right to receive health care.  Medical, political, and cultural 
factors must be weighed.  A diverse work force is needed to manage the health needs of a 
diverse population. 
Project Strengths and Limitations 
Strengths of the project included patients having similar risk factors.  
Management of care involved medication management along with certain procedural 
tests to check the functioning of the heart. 
Limitations cannot establish cause and effect with qualitative data. 
Recommendations for remediation of limitations in future work will involve 
having more women participate in clinical trials.  A gender analysis can be performed to 
address specific risk factors and treatment modalities catered to women’s needs. 
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Analysis of Self 
As a scholar Learning is fundamental and constantly evolving.  Through 
education, competencies, and specializations, there is a sense of being well versed in the 
subject matter, in order to lead, direct, and provide education to others. 
As a practitioner the tools have been received to practice the art and science of 
nursing proficiently, and further pursue the gaining of knowledge through research. 
As a project developer There has been engagement to learn how to take a 
concept and potentially build on it, until it becomes an idea put into motion.  Having a 
clear purpose of goals to make a project come into fruition, involves planning, and 
decision making.  Knowing where to consult for resources is beneficial. 
Future professional development of the project will involve having key 
stakeholders participate in random controlled clinical trials, along with expert researchers 
and clinicians.  Local, state, and national government need to be involvement so the 
healthcare agenda of women with coronary artery disease can be addressed and policy 
exacted. 
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Section 5: Scholarly Product for Dissemination 
A deeper understanding has been achieved regarding the specific signs and 
symptoms of coronary artery disease in women.  Through scholarly rigor, existing data 
on coronary artery disease has been interpreted and new findings presented.  
Dissemination of the project for nursing knowledge is crucial for advanced practice 
nurses.  It is hoped the project will communicate issues pertaining to coronary artery 
disease in women to health professionals, interdisciplinary teams, policy makers, and the 
media . Publication is a means of making information known about an issue. The project 
has devised a strategy to raise community awareness on the subject.  Educating the 
community through public events can help women understand symptoms associated with 
CAD and obtain the necessary treatment.  To reach the masses, information can be 
disseminated through church bulletins, fitness centers, businesses, and at places of 
employment (specifically, the coffee break room).  According to Jouria (2015),  
A meta-analysis of presenting cardiovascular symptoms in women and men was 
performed to determine whether sex-based differences in presentation were 
significant enough to warrant public health messages targeted specifically toward 
women and men.  The analysis found that across studies, lack of chest pain or 
discomfort was more commonly noted in women than in men.  However, the 
studies examined lacked standardized data collection and symptom reporting; 
therefore, the authors concluded that sex-based differences were not significant to 
prompt changing public health messages (p.38). 
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Summary 
Outcomes of treatments for women with coronary artery disease will be better 
understood when there is a large population of women to partake in clinical trials.  A 
meta-analysis of literature can be scrutinized to determine the best course of action in 
treatment interventions.  According to Jouria (2015), “some new research currently 
underway and new steps being taken for cardiovascular disease prevention and treatment 
include the use of cancer drugs to treat pulmonary hypertension, gene-therapy for use in 
the development of ventricular assist devices, clinical trials of the TransMedics Organ 
Care System, which is a device designed to keep the heart beating while it is en route for 
transplantation.  This results in better preservation of the donor heart” (p.36). 
According to Wenger (2012), “based on research studies, emerging data have 
highlighted important sex differences in the pathophysiology and clinical presentation of 
CHD in women and sex disparities in preventive interventions and diagnostic strategies, 
in management of acute coronary syndromes, and in the response to therapies, with 
consequent adverse outcomes of CHD in women.  Underuse of guideline-based 
preventive and therapeutic strategies for women substantially contributes to their less 
favorable CHD outcomes, but the spectrum of sex-based differences likely reflect both 
biology and bias” (p.605).  The Institute of Medicine has conducted investigations 
between 2001 and 2011 to evaluate sex-based differences in relation to disease processes 
and putting it into evidence-based practice (Wenger, 2012). 
It has long been thought that coronary artery disease only affects men.  This is 
based on numerous clinical studies being performed only on men.    New studies on the 
disease show how risk factors affect both genders differently.  Millions of women die 
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each year from coronary artery disease.  Many women that have succumbed to the effects 
of the disease have never showed any previous symptoms.  In the United States, 
cardiovascular disease is the leading cause of death for women. Clinical trials have 
shown that women have specific risk factors related to autoimmune disorders, such as 
pregnancy and microvascular disease.  For this reason, coronary artery disease should be 
managed differently in women.  Women who suffer from autoimmune disorders such as 
lupus, rheumatoid arthritis, and other inflammatory disorders tend to develop 
atherosclerosis at an accelerated rate.  Illness and death rises, due to adverse cardiac 
events.  Atherosclerosis is a disease in which plaque lines an artery.  Women who 
develop this disease are prone to blood clot formation.  Women who smoke are at risk of 
developing coronary disease.  The use of oral contraceptives increases the risk of deep 
vein thrombosis.  Hormonal replacement therapy should not be used in primary and 
secondary prevention of coronary artery disease.  Older women who become pregnant 
may experience acute coronary syndrome, which places mother and baby at high risk of 
death due to myocardial ischemia.  With myocardial ischemia, the blood flow to the heart 
is lessened, or there is complete blockage of the coronary arteries, leading to decreased 
oxygen perfusion to the body.  Acute coronary syndrome houses several disorders that 
can reduce blood flow to the heart, for example unstable angina and myocardial 
infarction (Durante & Bronzato, 2015). 
The risk profiles of the 31 cardiology patients used for the project showed all of 
them had a history of smoking tobacco, high cholesterol levels, high blood pressure, and 
hyperlipidemia, which are high levels of fats in the blood.  A few of the patients used 
illicit drugs, specifically cocaine, heroin, and marijuana.  Many of the patients had 
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damage to the heart muscle, heart valves, or coronary arteries.  Twenty-two of the 
patients were female, and nine were men. 
There are two blood chemistry tests that show better results for women, to 
indicate ischemic changes.  B-type natriuretic peptide (BNP) is secreted from the lower 
chamber of the heart, which are the ventricles.  If pressure changes in the heart vessels, it 
signifies heart failure.  C-reactive protein (CRP) is another test.  The liver produces this 
protein in response to injury of the heart. 
The field of nursing’s impact on outcomes with women with coronary artery 
disease is primary prevention and management of coronary artery disease.  For the 
purpose of the study, a risk assessment evaluation tool was utilized.  The tool helps to 
determine the ten-year risk of an individual developing heart disease, progressing to 
possibly experiencing a heart attack, stroke, or worse death.  There are several risk 
factors that cardiologist use, to determine a person’s risk profile for heart disease.  These 
risks include a family history of heart disease, smoking tobacco, consuming alcoholic 
beverages, obesity, lack of exercise, use of illicit drugs, having high blood pressure, high 
cholesterol levels, and an unhealthy diet.  These risk factors can be improved and 
changed by modifying one’s lifestyle and incorporating new habits that lead to 
maintaining optimal health.  Age, race, and gender are all risk factors for heart disease 
that cannot be changed.  
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The risk assessment tool asks a series of questions to try and predict the 
probability of a person having a heart attack.  The questions center on the person’s age, 
sex, and smoking history, family history of heart disease, total cholesterol, and high-
density lipoprotein (HDL) values.  The individual is asked if they take medicine to treat 
high blood pressure, and if they know the value of the systolic blood pressure that is most 
current.  Each question receives a number that is based on the National Cholesterol 
Education Program.  The scores range from low risk, intermediate risk, and highest risk.  
A risk score of less than 10% shows a decreased chance of dying from heart disease in 
the next ten years, or having a heart attack.  An intermediate risk score shows a 10%-20% 
chance that an individual will die in the next ten years from coronary artery disease, or 
experience a myocardial infarction.  The highest risk score is greater than a 20% risk of 
having a heart attack, or dying from heart disease (Cleveland Clinic, 2016). 
Over sixty years ago, there was a study conducted in a suburban city in 
Massachusetts called Framingham.  Scientist recruited residents for the Framingham 
Heart Study.  The participants ranged in age from 30-50, and ethnicity was Caucasian.  
During the turn of the 20th century, cardiovascular disease was on the rise, and scientist 
wanted to know why this was occurring.  The participants did not have heart disease at 
the time of the study, and were followed for over 40 years to see who from the list of 
participants developed cardiovascular disease.  The men and women who participated in 
the study totaled close to over five thousand individuals.  The scientist worked for an 
organization called the National Heart Institute. 
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The first published data identifying risk factors for developing coronary artery 
disease came from the Framingham Heart Study.  Moving forward to the 21st century, the 
National Heart Institute is now known as the National Heart, Lung, and Blood Institute 
(Framington.org, 2015).   A new generation is participating in the Framingham Heart 
Study.  These new cohorts of recruits are the children and grandchildren of the original 
recruits of the study.  Research is still going on, and other health problems are being 
investigated.  There are modern technologies that exist today, such as stress tests, CAT 
scans, and echocardiograms to help with diagnosing heart problems.  The Framingham 
Heart Study is utilizing this technology in their studies to further investigate heart related 
issues. 
Princeton New Jersey Longevity Center offers advanced technology, such as full 
body scans, which can locate calcium deposit build up in an artery.  The imaging of the 
full body scan can also discover aneurysms, heart disease, cancers, as well as vascular 
diseases.  The Princeton Longevity Center is also optimizing the use of high definition 
heart scans and virtual catheterization (Princeton Longevity Center, 2016). 
Advanced practice nurses are managing patients with multiple risk factors for 
many health problems, and are taking on provider roles to increase the quality of care for 
patients.  Many patients are receiving interventions with drug therapy.  Low dose baby 
aspirin provides anticoagulant therapy by thinning the blood to decrease the clots.  Beta-
blocker medications are used to control high blood pressure.  Statin medications help to 
reduce cholesterol levels.  Diuretic medication helps the kidneys to rid the body of extra 
salt and water.  Ace inhibitor medications help to lower the blood pressure by dilating the 
blood vessels. 
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In conclusion, many women are still not aware of the effects of coronary artery 
disease.  Hopefully in the future, more studies will be conducted on gender differences in 
heart disease, and more women will voluntarily participate in clinical trials; this will 
empower women to become advocates for their own health. 
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Classification of Coronary Artery Disease 
 
 
 Sharma, K., & Gulati, M. (2013). Coronary artery disease in women: A 2013 
Update. http://world-heart-federation.org/fileadmin/user_upload/images/grfw-
material/CADwomen.pdf 
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Heart and Coronary Artery Figure 
Figure A is an overview of a heart and coronary artery showing damage (dead heart 
muscle) caused by a heart attack. Figure B is a cross-section of the coronary artery 
with plaque buildup and a blood clot resulting from plaque rupture. 
  
National Heart, Lung, and Blood Institute (2014). How does heart disease affect women?  
http://www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/images_256 
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